8.520
+0,24%
2026-10-19
Fundamental Analysis
80 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +600.0% | +1313.8% | 3 / 3 | +46.1% | +3.65 pp | +1.92 pp | +10.6% | 0.88 | 5.84 | 688 | +46,1% | 16,7 | +600,0% | 5.84 | 8.12 | −28,1% |
| Pts | 12 | 12 | 12 | 12 | 12 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 8.520 (close price on 2026-10-19)EPS (TTM): 1.458
Financial charts
1.Revenue & growth
VND bn682Q2/26
1.Revenue & growth
VND bn682Q2/26
2.Profit & growth
VND bn17,4Q2/26
3.Profit mix (Penman)
VND bn137Q2/26
4.Margins & cost structure
%8.8%Q2/26
5.Returns & cash cycle
% · days6.7%Q2/26
6.Earnings quality & cash
VND bn243Q2/26
7.Asset structure
VND bn2.247Q2/26
8.Funding & debt health
VND bn · times2.247Q2/26
9.Revenue backlog
VND bn12,5Q2/26
10.Valuation
times · %6,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %219Q2/26
Adjusted EPS growth, latest quarter
628%
Average adjusted EPS growth, 3 quarters
14,2× higher
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26